Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Editorial
    • Multi-Drug Resistant...

    Multi-Drug Resistant organisms causing deadly Infections spreading in Community : SGRH Study

    Written by Anjali Nimesh Nimesh Published On 2017-11-17T19:00:53+05:30  |  Updated On 17 Nov 2017 7:00 PM IST
    Multi-Drug Resistant organisms causing deadly Infections spreading in Community  : SGRH Study

    Researchers from Department of Critical Care, Sir Ganga Ram Hospital, and City Hospital have conducted a retrospective study on 201 patients of Community-Acquired Infections and have found that classically ‘ Hospital ‘ strains which were drug-resistant with high mortality are now spreading in the community too. The study titled “ Association of high mortality with extended–spectrum β-lactamase (ESBL) positive cultures in community-acquired infections which has been accepted for publication in Journal of Critical Care was done on 201 patients who did not come into contact with any health care facility in last three months or more.


    Infections due to multidrug-resistant organisms have become a serious health concern worldwide. The present study was conducted to investigate the spectrum of microbial resistance pattern in the community and their effects on mortality.


    According to Dr Sumit Ray, Author of the study & Vice-Chairman, Department of Critical Care, Sir Ganga Ram Hospital, “ The distinction between community-acquired and hospital-acquired infections is becoming increasingly blurred. The main reasons for this are the spread of classically 'hospital' strains, particularly resistant Klebsiella and E. Coli, into the community and vice versa, and the repeated admissions of individuals to hospitals with long-standing underlying diseases. In addition, the contribution of antibiotic resistance in the community through easily available antibiotics often used without medical supervision has resulted in an increasing reservoir of potential infections .”


    Dr Ray said, “ The resistance to high-end antibiotics by organisms contracted by patients in the community resulting in high mortality, seen in our study, is a cause for worry and needs further research and proper action plan .”


    Infections due to multidrug-resistant (MDR) gram-negative organisms particularly those producing extended spectrum β lactamases (ESBLs) are of major concern worldwide. ESBLs are organisms - resistant to various newer generation antibiotics and can be easily transferred to the community. These resistant infections pose therapeutic challenges to clinicians in the treatment of these patients and may, therefore, be associated with high morbidity and mortality.


    Dr Ray further added, “ The striking point noted in our results is the emergence of E.coli as most common bacteria in the community causing bacteremia, respiratory and urinary tract infection and higher mortality in ESBL positive producers as compared to ESBL negative producers. A high percentage (63.44%) of these E. coli was ESBL producers. This reflects the increased resistance pattern to high-end antibiotics in Hospital Acquired Infections due to inadvertent early use of 3rd generation cephalosporins in the last decade, which is further trickling over into the community, because of plasmid-mediated transfer of its genetic materials during conjugation. “


    According to Dr Debashish Dhar, Author and Consultant, Department of Critical Care, City Hospital, “ In our study, the predominant pathogens isolated from community-acquired infections were E.coli (46.2%) followed by Klebsiella pneumonia (13.9%) and S. aureus (13.9%).”

    cephalosporinscritical careDr Sumit RayMulti-drug resistantSGRHSir Ganga Ram Hospital
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Anjali Nimesh Nimesh
    Anjali Nimesh Nimesh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok